This is an exciting and rewarding time to begin a career in biomedical research. The pace of scientific discovery is breathtaking. Endless opportunities exist for our graduates as they begin their careers.
Extraordinary research opportunities are available within the Department of Microbiology and Immunology and collaborative research units including the Division of Infectious Disease and HIV Medicine in the areas of:
- Molecular and human genetics
- Malarial and bacterial pathogenesis
- Emerging disease and biodefense
- Opportunistic infections
- Experimental therapeutics and diagnostics
- Cancer biology
Continued advances in technology and collaborative interdisciplinary research between basic and clinical scientists will be the key to innovation and new discovery in the next decade. Research conducted within the department will be of tremendous importance to the growing national and international health care needs.
We are committed to understanding molecular mechanisms of infectious diseases within the human population and the development of strategies to prevent and/or treat these acute, chronic, and latent infectious diseases.
The research programs of our faculty are funded by the National Institute of Allergy and Infectious Disease, National Institute of Neurological Disorders and Stroke, National Cancer Institute, National Institute of Child Health and Human Development, National Institute of General Medical Science and the National Multiple Sclerosis Society.
For more information on individual faculty members, their research interests, and training opportunities offered by our outstanding faculty, please explore the department's web page through the links at the left.
Meet Our Faculty - Joris Beld, PhD
"My lab is interested in natural products. In other words, we're interested in molecules that we get from nature. If you go to a hospital and you look at the list of drugs they prescribe to patients, you'll find that roughly 75 percent of those are derived from natural products. Those drugs are not something that chemists have invented. They're made from molecules that we've borrowed from nature."
Read more from Dr. Beld
News and Announcements
"New Drug Could Treat Parkinson's"
More than 6 million people suffer from Parkinson's disease worldwide, and that number is predicted to double by the year 2030. Current treatment with L-dopa drugs leaves much to be desired. Most patients — as many as 80 percent — who take L-dopa drugs develop dyskinesia, a painful involuntary movement disorder, within five years.
Pulse (Fall 2015)
"Two Drexel Faculty Members Named 2014 AAAS Fellows"
Two Drexel University faculty members have been named fellows of the American Association for the Advancement of Science (AAAS). Garth Ehrlich, PhD, professor in the Department of Microbiology & Immunology at Drexel University College of Medicine; and Karen Moxon, PhD, professor in the Department of Neurobiology & Anatomy at the College of Medicine and professor at the School of Biomedical Engineering, Sciences & Health Systems, were both elected for the honor by their peers because of their scientifically or socially distinguished efforts to advance science or its applications.
(December 8, 2014)
"ASM Watkins Fellowship"
The ASM Robert D. Watkins Graduate Research Fellowship is aimed at highly competitive graduate students who are enrolled in a PhD program and who have completed their graduate course work in the microbiological sciences. The fellowship encourages students to continue and complete their research project in the microbiological sciences. The application deadline is May 1, 2016.
Upcoming and Recent Events
Friday, May 27, noon, Queen Lane SAC B
F. Javier Gamo, PhD, director, Malaria Discovery Performance Unit, Diseases of the Developing World, Glaxo Smith Kline:
"Antimalarial Lead Discovery: Exploiting Phenotypic Hits"
2016 Research Seminar Schedule
Back to Top